imipenem , a potent new beta-lactam antibiotic , which is bactericidal against most pathogenic bacteria , and cilastatin , a dehydropeptidase inhibitor combined with imipenem to prevent the metabolism of imipenem in the kidney , were evaluated in the treatment of bacterial endocarditis .
C0008777
cilastatin
C0014121
bacterial endocarditis